US2006128627A1PendingUtilityA1

Human appetite control by glucagon-like peptide receptor binding compounds

Assignee: AMYLIN PHARMACEUTICALS INCPriority: Mar 19, 1998Filed: Feb 6, 2006Published: Jun 15, 2006

Est. expiryMar 19, 2018(expired)· nominal 20-yr term from priority

Inventors:Burkhard J. Göke Christoph Beglinger Thomas R. Coolidge

A61K 38/26

PatentIndex Score

Cited by

References

Claims

Abstract

A composition including a compound which binds to a receptor for glucagon-like peptide-1 and a pharmaceutical carrier. The amount of the compound present is effective to control appetite in a human. Also disclosed is a method for controlling appetite and for reducing food intake in a human by administering to the human a composition comprising a compound which binds to a receptor for glucagon-like peptide-1 and a pharmaceutical carrier.

Claims

exact text as granted — not AI-modified

1 . A method for controlling appetite in a human by administering to the human a composition comprising: a compound which binds to a receptor for glucagon-like peptide-1 and a pharmaceutical carrier, said composition containing an amount of said compound effective to control appetite in a human.  
     
     
         2 . A method for reducing spontaneous food intake in a human by administering to the human a composition comprising: a compound which binds to the receptor for glucagon-like peptide-1 and a pharmaceutical carrier, said composition containing an amount of said compound effective to reduce spontaneous food intake in a human.

Join the waitlist — get patent alerts

Track US2006128627A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.